135 related articles for article (PubMed ID: 14613768)
1. Synthesis, structure, and screening of estrogenic and antiestrogenic activity of new 3,17-substituted-16,17-seco-estratriene derivatives.
Jovanović-Santa S; Petrović J; Andrić S; Kovacević R; Durendić E; Sakac M; Lazar D; Stanković S
Bioorg Chem; 2003 Dec; 31(6):475-84. PubMed ID: 14613768
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and estrogen activity screening of some new D-secoestrone derivatives.
Petrović JA; Pejanović VM; Miljković DA; Hranisavljević JT
Steroids; 1990 Jun; 55(6):276-8. PubMed ID: 2385852
[TBL] [Abstract][Full Text] [Related]
3. Antihormonal potential of selected D-homo and D-seco estratriene derivatives.
Jovanović-Šanta SS; Petri ET; Klisurić OR; Szécsi M; Kovačević R; Petrović JA
Steroids; 2015 May; 97():45-53. PubMed ID: 25204595
[TBL] [Abstract][Full Text] [Related]
4. D-Secoestrone derivatives. V1. 3-Methoxy-17-oxo-17-phenyl-16,17-secoestra-1,3,5(10)-triene-16-nitrile and 17-hydroxy-3-methoxy-17-phenyl-16,17-secoestra-1,3,5(10)-triene-16-nitrile.
Lazar D; Stanković S; Pejanović V; Courseille C
Acta Crystallogr C; 2002 Feb; 58(Pt 2):o63-5. PubMed ID: 11828109
[TBL] [Abstract][Full Text] [Related]
5. Preparation of 14,15-secoestra-1,3,5(10)-trien-15-ynes, inhibitors of estradiol dehydrogenase.
Auchus RJ; Palmer JO; Carrell HL; Covey DF
Steroids; 1989; 53(1-2):77-96. PubMed ID: 2772972
[TBL] [Abstract][Full Text] [Related]
6. Estrogenic and antiestrogenic activity of monophenolic analogues of tamoxifen, (Z)-2-[p-(1,2-diphenyl-1-butenyl)phenoxy]-N, N-dimethylethylamine.
Ruenitz PC; Bagley JR; Mokler CM
J Med Chem; 1982 Sep; 25(9):1056-60. PubMed ID: 7131484
[TBL] [Abstract][Full Text] [Related]
7. C-nor-9,11-secoestranes as modified estrogens and fertility regulation.
Lal K; Sharma I; Agarwal AK; Agnihotri A; Ray S
J Med Chem; 1988 Jun; 31(6):1261-4. PubMed ID: 3373496
[TBL] [Abstract][Full Text] [Related]
8. Regulation of prolactin synthesis in vitro by estrogenic and antiestrogenic derivatives of estradiol and estrone.
Jordan VC; Koch R
Endocrinology; 1989 Apr; 124(4):1717-26. PubMed ID: 2924721
[TBL] [Abstract][Full Text] [Related]
9. Studies in antifertility agents. 11. Secosteroids. 5. Synthesis of 9,11-secoestradiol.
Kole P; Ray S; Kamboj VP; Anand N
J Med Chem; 1975 Jul; 18(7):765-6. PubMed ID: 1152000
[TBL] [Abstract][Full Text] [Related]
10. Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterus.
Jordan VC; Gosden B
Mol Cell Endocrinol; 1982 Aug; 27(3):291-306. PubMed ID: 7128917
[No Abstract] [Full Text] [Related]
11. Synthesis and biological activity of 17 alpha-alkynylamide derivatives of estradiol.
Poirier D; Labrie C; Mérand Y; Labrie F
J Steroid Biochem Mol Biol; 1991 Jun; 38(6):759-74. PubMed ID: 2064992
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel N-substituted N'-(3-hydroxy-17-oxoestra-1,3,5(10)-trien-2- and -4-yl)thiourea derivatives for binding to the estrogen receptor and cytotoxic activity on MCF-7 cells.
Omar AM; Aboulwafa OM; Leclercq G
J Pharm Sci; 1984 Dec; 73(12):1871-3. PubMed ID: 6441843
[TBL] [Abstract][Full Text] [Related]
13. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
Borgna JL; Scali J
Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
Murphy CS; Parker CJ; McCague R; Jordan VC
Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the dissociation rate between the vaginotrophic and uterotrphic activities of 1-hydroxy-1, 3, 5 (10)-estratriene derivatives with natural and unnatural configuration at C8 using ovariectomized mice.
Nishino Y; Neumann F; Prezewowsky K; Wiechert R
Steroids; 1976 Sep; 28(3):325-57. PubMed ID: 982491
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis, structure, and biological properties of some 8alpha-analogues of steroid estrogens with fluorine in position 2].
Belov VN; Dudkin VIu; Urusova EA; Starova GL; Selivanov SI; Nikolaev SV; Eshchenko ND; Morozkina SN; Shavva AG
Bioorg Khim; 2007; 33(3):315-23. PubMed ID: 17682387
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activities of thioether derivatives related to the antiestrogens tamoxifen and ICI 164384.
Auger S; Mérand Y; Pelletier JD; Poirier D; Labrie F
J Steroid Biochem Mol Biol; 1995 Jun; 52(6):547-65. PubMed ID: 7779759
[TBL] [Abstract][Full Text] [Related]
18. 2-Phenylindenes: development of a new mammary tumor inhibiting antiestrogen by combination of estrogenic side effect lowering structural elements.
Schneider MR; Ball H
J Med Chem; 1986 Jan; 29(1):75-9. PubMed ID: 3941415
[TBL] [Abstract][Full Text] [Related]
19. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin.
Liu X; Zhang F; Liu H; Burdette JE; Li Y; Overk CR; Pisha E; Yao J; van Breemen RB; Swanson SM; Bolton JL
Chem Res Toxicol; 2003 Jun; 16(6):741-9. PubMed ID: 12807357
[TBL] [Abstract][Full Text] [Related]
20. 3-Alkyl-2-phenylbenzo[b]thiophenes: nonsteroidal estrogen antagonists with mammary tumor inhibiting activity.
von Angerer E; Erber S
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):557-62. PubMed ID: 1562527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
